<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-11T05:00:20Z</responseDate>
  <request identifier="oai:figshare.com:article/33937774" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33937774</identifier>
        <datestamp>2026-09-18T17:27:35Z</datestamp>
        <setSpec>category_7</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_46</setSpec>
        <setSpec>category_64</setSpec>
        <setSpec>category_106</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_5</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>&lt;p&gt;Differences in vital signs and laboratory tests, as documented in medical records.&lt;/p&gt;</dc:title>
          <dc:creator>Vera Logan (20671065)</dc:creator>
          <dc:creator>Alex Conboy (25073155)</dc:creator>
          <dc:creator>Neil Carter (845595)</dc:creator>
          <dc:creator>David Hughes (47111)</dc:creator>
          <dc:creator>Adam Turner (8983262)</dc:creator>
          <dc:creator>Alan Watkins (432126)</dc:creator>
          <dc:creator>Sue Jordan (432125)</dc:creator>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Immunology</dc:subject>
          <dc:subject>Cancer</dc:subject>
          <dc:subject>Science Policy</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>patient using metformin</dc:subject>
          <dc:subject>p &gt;&amp;# 8220</dc:subject>
          <dc:subject>one problem addressed</dc:subject>
          <dc:subject>comprising six practices</dc:subject>
          <dc:subject>benefit following referrals</dc:subject>
          <dc:subject>82 %] vs</dc:subject>
          <dc:subject>participants &amp;# 8217</dc:subject>
          <dc:subject>randomized controlled trial</dc:subject>
          <dc:subject>randomised controlled trial</dc:subject>
          <dc:subject>practice medical records</dc:subject>
          <dc:subject>avoidable harm due</dc:subject>
          <dc:subject>adverse drug reaction</dc:subject>
          <dc:subject>intervention proved critical</dc:subject>
          <dc:subject>27 vs 24</dc:subject>
          <dc:subject>patients &amp;# 8217</dc:subject>
          <dc:subject>control arm patients</dc:subject>
          <dc:subject>intervention arm completed</dc:subject>
          <dc:subject>address clinical problems</dc:subject>
          <dc:subject>intervention arm patients</dc:subject>
          <dc:subject>study &amp;# 8217</dc:subject>
          <dc:subject>second adre profile</dc:subject>
          <dc:subject>trial arm</dc:subject>
          <dc:subject>&amp;# 8211</dc:subject>
          <dc:subject>clinical problems</dc:subject>
          <dc:subject>patients completed</dc:subject>
          <dc:subject>second profiles</dc:subject>
          <dc:subject>proved difficult</dc:subject>
          <dc:subject>practice pharmacist</dc:subject>
          <dc:subject>iatrogenic harm</dc:subject>
          <dc:subject>adverse effects</dc:subject>
          <dc:subject>two patients</dc:subject>
          <dc:subject>three patients</dc:subject>
          <dc:subject>60 patients</dc:subject>
          <dc:subject>xlink "&gt;</dc:subject>
          <dc:subject>west wales</dc:subject>
          <dc:subject>usual care</dc:subject>
          <dc:subject>term medicines</dc:subject>
          <dc:subject>symptoms recorded</dc:subject>
          <dc:subject>reducing risk</dc:subject>
          <dc:subject>random intercept</dc:subject>
          <dc:subject>process evaluation</dc:subject>
          <dc:subject>primary care</dc:subject>
          <dc:subject>prescribed medicines</dc:subject>
          <dc:subject>incomplete monitoring</dc:subject>
          <dc:subject>flecainide de</dc:subject>
          <dc:subject>confidence interval</dc:subject>
          <dc:description>&lt;p&gt;Differences in vital signs and laboratory tests, as documented in medical records.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-18T17:27:21Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.1371/journal.pone.0356480.t004</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_p_Differences_in_vital_signs_and_laboratory_tests_as_documented_in_medical_records_p_/33937774</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
